Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Human leukocyte antigen-associated HIV-1 CRF02_AG gag and vif polymorphisms in Ghana.

Adusei-Poku MA, Matsuoka S, Bonney EY, Abana CZ, Duker EO, Nii-Trebi NI, Ofori SB, Mizutani T, Ishizaka A, Shiino T, Kawana-Tachikawa A, Ishikawa K, Ampofo WK, Matano T.

Jpn J Infect Dis. 2019 Jun 28. doi: 10.7883/yoken.JJID.2019.201. [Epub ahead of print]

2.

HIV-1 matrix mutations that alter gag membrane binding modulate mature core formation and post-entry events.

Hikichi Y, Takeda E, Fujino M, Nakayama E, Matano T, Murakami T.

Virology. 2019 Apr 27;532:97-107. doi: 10.1016/j.virol.2019.04.013. [Epub ahead of print]

PMID:
31055063
3.

CD8+ T cell-based strong selective pressure on multiple simian immunodeficiency virus targets in macaques possessing a protective MHC class I haplotype.

Hau TTT, Nakamura-Hoshi M, Kanno Y, Nomura T, Nishizawa M, Seki S, Ishii H, Kawana-Tachikawa A, Hall WW, Nguyen Thi LA, Matano T, Yamamoto H.

Biochem Biophys Res Commun. 2019 Apr 30;512(2):213-217. doi: 10.1016/j.bbrc.2019.03.003. Epub 2019 Mar 14.

PMID:
30878187
4.

CD8+ Cytotoxic-T-Lymphocyte Breadth Could Facilitate Early Immune Detection of Immunodeficiency Virus-Derived Epitopes with Limited Expression Levels.

Tsukamoto T, Yamamoto H, Matano T.

mSphere. 2019 Jan 9;4(1). pii: e00381-18. doi: 10.1128/mSphere.00381-18.

5.

Diversity of ULBP5 in Old-World monkeys (Cercopithecidae) and divergence of the ULBP gene family in primates.

Naruse TK, Akari H, Matano T, Kimura A.

Proc Jpn Acad Ser B Phys Biol Sci. 2018;94(10):441-453. doi: 10.2183/pjab.94.029.

6.

Human leukocyte antigen-associated gag and nef polymorphisms in HIV-1 subtype A/E-infected individuals in Vietnam.

Takahashi N, Matsuoka S, Thi Minh TT, Ba HP, Naruse TK, Kimura A, Shiino T, Kawana-Tachikawa A, Ishikawa K, Matano T, Nguyen Thi LA.

Microbes Infect. 2019 Mar;21(2):113-118. doi: 10.1016/j.micinf.2018.10.001. Epub 2018 Oct 30.

PMID:
30385305
7.

The importance of accounting for testing and positivity in surveillance by time and place: an illustration from HIV surveillance in Japan.

Kato H, Kanou K, Arima Y, Ando F, Matsuoka S, Yoshimura K, Matano T, Matsui T, Sunagawa T, Oishi K.

Epidemiol Infect. 2018 Dec;146(16):2072-2078. doi: 10.1017/S0950268818002558. Epub 2018 Sep 12.

8.

A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction.

Saso W, Tsukuda S, Ohashi H, Fukano K, Morishita R, Matsunaga S, Ohki M, Ryo A, Park SY, Suzuki R, Aizaki H, Muramatsu M, Sureau C, Wakita T, Matano T, Watashi K.

Biochem Biophys Res Commun. 2018 Jun 22;501(2):374-379. doi: 10.1016/j.bbrc.2018.04.187. Epub 2018 May 11.

PMID:
29730285
9.

Characterization of In Vitro Expanded Virus-Specific T cells for Adoptive Immunotherapy against Virus Infection.

Ono T, Fujita Y, Matano T, Takahashi S, Morio T, Kawana-Tachikawa A.

Jpn J Infect Dis. 2018 Mar 22;71(2):122-128. doi: 10.7883/yoken.JJID.2017.500. Epub 2018 Feb 28.

10.

Dynamic HIV-1 genetic recombination and genotypic drug resistance among treatment-experienced adults in northern Ghana.

Nii-Trebi NI, Brandful JAM, Ibe S, Sugiura W, Barnor JS, Bampoh PO, Yamaoka S, Matano T, Yoshimura K, Ishikawa K, Ampofo WK.

J Med Microbiol. 2017 Nov;66(11):1663-1672. doi: 10.1099/jmm.0.000621. Epub 2017 Oct 25.

PMID:
29068286
11.

In vivo virulence of MHC-adapted AIDS virus serially-passaged through MHC-mismatched hosts.

Seki S, Nomura T, Nishizawa M, Yamamoto H, Ishii H, Matsuoka S, Shiino T, Sato H, Mizuta K, Sakawaki H, Miura T, Naruse TK, Kimura A, Matano T.

PLoS Pathog. 2017 Sep 20;13(9):e1006638. doi: 10.1371/journal.ppat.1006638. eCollection 2017 Sep.

12.

First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.

Nyombayire J, Anzala O, Gazzard B, Karita E, Bergin P, Hayes P, Kopycinski J, Omosa-Manyonyi G, Jackson A, Bizimana J, Farah B, Sayeed E, Parks CL, Inoue M, Hironaka T, Hara H, Shu T, Matano T, Dally L, Barin B, Park H, Gilmour J, Lombardo A, Excler JL, Fast P, Laufer DS, Cox JH; S001 Study Team.

J Infect Dis. 2017 Jan 1;215(1):95-104. doi: 10.1093/infdis/jiw500. Epub 2016 Oct 17.

13.

First Complete Genome Sequence of a Simian Foamy Virus Isolate from a Cynomolgus Macaque.

Sakai K, Ami Y, Suzaki Y, Matano T.

Genome Announc. 2016 Dec 1;4(6). pii: e01332-16. doi: 10.1128/genomeA.01332-16.

14.

Patterns of HIV/SIV Prevention and Control by Passive Antibody Immunization.

Yamamoto H, Matano T.

Front Microbiol. 2016 Nov 2;7:1739. eCollection 2016. Review.

15.

Augmentation of anti-simian immunodeficiency virus activity in CD8+ cells by neutralizing but not nonneutralizing antibodies in the acute phase.

Yamamoto H, Iseda S, Nakane T, Nomura T, Takahashi N, Seki S, Nakamura M, Ishii H, Matano T.

AIDS. 2016 Sep 24;30(15):2391-4. doi: 10.1097/QAD.0000000000001221. No abstract available.

PMID:
27603164
16.
17.

Association of lymph-node antigens with lower Gag-specific central-memory and higher Env-specific effector-memory CD8(+) T-cell frequencies in a macaque AIDS model.

Ishii H, Matsuoka S, Nomura T, Nakamura M, Shiino T, Sato Y, Iwata-Yoshikawa N, Hasegawa H, Mizuta K, Sakawaki H, Miura T, Koyanagi Y, Naruse TK, Kimura A, Matano T.

Sci Rep. 2016 Jul 25;6:30153. doi: 10.1038/srep30153.

18.

Increased HIV-1 sensitivity to neutralizing antibodies by mutations in the Env V3-coding region for resistance to CXCR4 antagonists.

Hikichi Y, Yokoyama M, Takemura T, Fujino M, Kumakura S, Maeda Y, Yamamoto N, Sato H, Matano T, Murakami T.

J Gen Virol. 2016 Sep;97(9):2427-40. doi: 10.1099/jgv.0.000536. Epub 2016 Jul 1.

PMID:
27368421
19.

Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.

Iseda S, Takahashi N, Poplimont H, Nomura T, Seki S, Nakane T, Nakamura M, Shi S, Ishii H, Furukawa S, Harada S, Naruse TK, Kimura A, Matano T, Yamamoto H.

J Virol. 2016 Jun 24;90(14):6276-6290. doi: 10.1128/JVI.00557-16. Print 2016 Jul 15.

20.

Broadening of Virus-Specific CD8+ T-Cell Responses Is Indicative of Residual Viral Replication in Aviremic SIV Controllers.

Nomura T, Yamamoto H, Ishii H, Akari H, Naruse TK, Kimura A, Matano T.

PLoS Pathog. 2015 Nov 4;11(11):e1005247. doi: 10.1371/journal.ppat.1005247. eCollection 2015.

21.

Development of a Sendai virus vector-based AIDS vaccine inducing T cell responses.

Seki S, Matano T.

Expert Rev Vaccines. 2016;15(1):119-27. doi: 10.1586/14760584.2016.1105747. Epub 2015 Oct 29. Review.

PMID:
26512881
22.

Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy.

Nishizawa M, Matsuda M, Hattori J, Shiino T, Matano T, Heneine W, Johnson JA, Sugiura W.

PLoS One. 2015 Sep 11;10(9):e0135941. doi: 10.1371/journal.pone.0135941. eCollection 2015.

23.

Development of an AIDS vaccine using Sendai virus vectors.

Ishii H, Matano T.

Vaccine. 2015 Nov 9;33(45):6061-5. doi: 10.1016/j.vaccine.2015.06.114. Epub 2015 Jul 29. Review.

PMID:
26232346
24.

Novel HIV-1 Recombinant Identified in a Foreign Heterosexual Resident in Japan: Relatedness to Recently Reported CRF69_01B, Detected Primarily among Japanese Men Who Have Sex with Men.

Kusagawa S, Yokota Y, Negishi M, Kondo M, Matano T, Kato S, Takebe Y.

Genome Announc. 2015 May 28;3(3). pii: e00196-15. doi: 10.1128/genomeA.00196-15.

25.

Vaccine-induced CD107a+ CD4+ T cells are resistant to depletion following AIDS virus infection.

Terahara K, Ishii H, Nomura T, Takahashi N, Takeda A, Shiino T, Tsunetsugu-Yokota Y, Matano T.

J Virol. 2014 Dec;88(24):14232-40. doi: 10.1128/JVI.02032-14. Epub 2014 Oct 1.

26.

Identification of SIV Nef CD8(+) T cell epitopes restricted by a MHC class I haplotype associated with lower viral loads in a macaque AIDS model.

Nomura T, Yamamoto H, Takahashi N, Naruse TK, Kimura A, Matano T.

Biochem Biophys Res Commun. 2014 Jul 25;450(2):942-7. doi: 10.1016/j.bbrc.2014.06.072. Epub 2014 Jun 24.

PMID:
24971540
27.

Intercontinental dispersal of HIV-1 subtype B associated with transmission among men who have sex with men in Japan.

Takebe Y, Naito Y, Raghwani J, Fearnhill E, Sano T, Kusagawa S, Mbisa JL, Zhang H, Matano T, Brown AJ, Pybus OG, Dunn D, Kondo M; UK Collaborative Group on HIV Drug Resistance.

J Virol. 2014 Sep 1;88(17):9864-76. doi: 10.1128/JVI.01354-14. Epub 2014 Jun 18.

28.

Divergence and diversity of ULBP2 genes in rhesus and cynomolgus macaques.

Naruse TK, Akari H, Matano T, Kimura A.

Immunogenetics. 2014 Mar;66(3):161-70. doi: 10.1007/s00251-014-0760-y. Epub 2014 Jan 28.

PMID:
24469065
29.

Tertiary mutations stabilize CD8+ T lymphocyte escape-associated compensatory mutations following transmission of simian immunodeficiency virus.

Burwitz BJ, Wu HL, Reed JS, Hammond KB, Newman LP, Bimber BN, Nimiyongskul FA, Leon EJ, Maness NJ, Friedrich TC, Yokoyama M, Sato H, Matano T, O'Connor DH, Sacha JB.

J Virol. 2014 Mar;88(6):3598-604. doi: 10.1128/JVI.03304-13. Epub 2013 Dec 26.

30.

Highly-sensitive allele-specific PCR testing identifies a greater prevalence of transmitted HIV drug resistance in Japan.

Nishizawa M, Hattori J, Shiino T, Matano T, Heneine W, Johnson JA, Sugiura W.

PLoS One. 2013 Dec 16;8(12):e83150. doi: 10.1371/journal.pone.0083150. eCollection 2013.

31.

Control of simian immunodeficiency virus replication by vaccine-induced Gag- and Vif-specific CD8+ T cells.

Iwamoto N, Takahashi N, Seki S, Nomura T, Yamamoto H, Inoue M, Shu T, Naruse TK, Kimura A, Matano T.

J Virol. 2014 Jan;88(1):425-33. doi: 10.1128/JVI.02634-13. Epub 2013 Oct 23.

32.

Limited impact of passive non-neutralizing antibody immunization in acute SIV infection on viremia control in rhesus macaques.

Nakane T, Nomura T, Shi S, Nakamura M, Naruse TK, Kimura A, Matano T, Yamamoto H.

PLoS One. 2013 Sep 9;8(9):e73453. doi: 10.1371/journal.pone.0073453. eCollection 2013.

33.

IL-21-producer CD4+ T cell kinetics during primary simian immunodeficiency virus infection.

Shi S, Seki S, Matano T, Yamamoto H.

Microbes Infect. 2013 Sep-Oct;15(10-11):697-707. doi: 10.1016/j.micinf.2013.06.004. Epub 2013 Jun 19.

PMID:
23791954
34.

TRIM5 genotypes in cynomolgus monkeys primarily influence inter-individual diversity in susceptibility to monkey-tropic human immunodeficiency virus type 1.

Saito A, Nomaguchi M, Kono K, Iwatani Y, Yokoyama M, Yasutomi Y, Sato H, Shioda T, Sugiura W, Matano T, Adachi A, Nakayama EE, Akari H.

J Gen Virol. 2013 Jun;94(Pt 6):1318-24. doi: 10.1099/vir.0.050252-0. Epub 2013 Mar 13.

PMID:
23486671
35.

Emergence in Japan of an HIV-1 variant associated with transmission among men who have sex with men (MSM) in China: first indication of the International Dissemination of the Chinese MSM lineage.

Kondo M, Lemey P, Sano T, Itoda I, Yoshimura Y, Sagara H, Tachikawa N, Yamanaka K, Iwamuro S, Matano T, Imai M, Kato S, Takebe Y.

J Virol. 2013 May;87(10):5351-61. doi: 10.1128/JVI.02370-12. Epub 2013 Jan 30.

36.

A novel protective MHC-I haplotype not associated with dominant Gag-specific CD8+ T-cell responses in SIVmac239 infection of Burmese rhesus macaques.

Takahashi N, Nomura T, Takahara Y, Yamamoto H, Shiino T, Takeda A, Inoue M, Iida A, Hara H, Shu T, Hasegawa M, Sakawaki H, Miura T, Igarashi T, Koyanagi Y, Naruse TK, Kimura A, Matano T.

PLoS One. 2013;8(1):e54300. doi: 10.1371/journal.pone.0054300. Epub 2013 Jan 14.

37.

Gag-CA Q110D mutation elicits TRIM5-independent enhancement of HIV-1mt replication in macaque cells.

Nomaguchi M, Yokoyama M, Kono K, Nakayama EE, Shioda T, Saito A, Akari H, Yasutomi Y, Matano T, Sato H, Adachi A.

Microbes Infect. 2013 Jan;15(1):56-65. doi: 10.1016/j.micinf.2012.10.013. Epub 2012 Nov 1.

PMID:
23123544
38.

Immunogenicity of repeated Sendai viral vector vaccination in macaques.

Kurihara K, Takahara Y, Nomura T, Ishii H, Iwamoto N, Takahashi N, Inoue M, Iida A, Hara H, Shu T, Hasegawa M, Moriya C, Matano T.

Microbes Infect. 2012 Nov;14(13):1169-76. doi: 10.1016/j.micinf.2012.07.016. Epub 2012 Jul 31.

PMID:
22884717
39.

Association of MHC-I genotypes with disease progression in HIV/SIV infections.

Nomura T, Matano T.

Front Microbiol. 2012 Jun 29;3:234. doi: 10.3389/fmicb.2012.00234. eCollection 2012.

40.

Lineage-specific evolution of T-cell immunoglobulin and mucin domain 1 gene in the primates.

Ohtani H, Naruse TK, Iwasaki Y, Akari H, Ishida T, Matano T, Kimura A.

Immunogenetics. 2012 Sep;64(9):669-78. doi: 10.1007/s00251-012-0628-y. Epub 2012 Jun 19.

PMID:
22710823
41.

[Therapeutic anti-HIV vaccine].

Nakamura M, Matano T.

Nihon Rinsho. 2012 Apr;70(4):676-80. Review. Japanese.

PMID:
22568153
42.

Association of major histocompatibility complex class I haplotypes with disease progression after simian immunodeficiency virus challenge in burmese rhesus macaques.

Nomura T, Yamamoto H, Shiino T, Takahashi N, Nakane T, Iwamoto N, Ishii H, Tsukamoto T, Kawada M, Matsuoka S, Takeda A, Terahara K, Tsunetsugu-Yokota Y, Iwata-Yoshikawa N, Hasegawa H, Sata T, Naruse TK, Kimura A, Matano T.

J Virol. 2012 Jun;86(12):6481-90. doi: 10.1128/JVI.07077-11. Epub 2012 Apr 4.

43.

CTL Escape and Viral Fitness in HIV/SIV Infection.

Seki S, Matano T.

Front Microbiol. 2012 Jan 4;2:267. doi: 10.3389/fmicb.2011.00267. eCollection 2011.

44.

Host cell species-specific effect of cyclosporine A on simian immunodeficiency virus replication.

Takeuchi H, Ishii H, Kuwano T, Inagaki N, Akari H, Matano T.

Retrovirology. 2012 Jan 6;9:3. doi: 10.1186/1742-4690-9-3.

45.

Impact of vaccination on cytotoxic T lymphocyte immunodominance and cooperation against simian immunodeficiency virus replication in rhesus macaques.

Ishii H, Kawada M, Tsukamoto T, Yamamoto H, Matsuoka S, Shiino T, Takeda A, Inoue M, Iida A, Hara H, Shu T, Hasegawa M, Naruse TK, Kimura A, Takiguchi M, Matano T.

J Virol. 2012 Jan;86(2):738-45. doi: 10.1128/JVI.06226-11. Epub 2011 Nov 9.

46.

Intranasal Sendai viral vector vaccination is more immunogenic than intramuscular under pre-existing anti-vector antibodies.

Moriya C, Horiba S, Kurihara K, Kamada T, Takahara Y, Inoue M, Iida A, Hara H, Shu T, Hasegawa M, Matano T.

Vaccine. 2011 Nov 3;29(47):8557-63. doi: 10.1016/j.vaccine.2011.09.028. Epub 2011 Sep 20.

PMID:
21939708
47.

[Current topics in prophylactic AIDS vaccine development].

Ishii H, Matano T.

Nihon Rinsho. 2011 Sep;69(9):1622-7. Review. Japanese.

PMID:
21922764
48.

Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses during primary simian immunodeficiency virus infection in Burmese rhesus macaques.

Nakamura M, Takahara Y, Ishii H, Sakawaki H, Horiike M, Miura T, Igarashi T, Naruse TK, Kimura A, Matano T, Matsuoka S.

Microbiol Immunol. 2011 Nov;55(11):768-73. doi: 10.1111/j.1348-0421.2011.00384.x.

49.

Diversity of MHC class I haplotypes in cynomolgus macaques.

Saito Y, Naruse TK, Akari H, Matano T, Kimura A.

Immunogenetics. 2012 Feb;64(2):131-41. doi: 10.1007/s00251-011-0568-y. Epub 2011 Sep 1.

PMID:
21881951
50.

ULBP4/RAET1E is highly polymorphic in the Old World monkey.

Naruse TK, Okuda Y, Mori K, Akari H, Matano T, Kimura A.

Immunogenetics. 2011 Aug;63(8):501-9. doi: 10.1007/s00251-011-0531-y. Epub 2011 May 7.

PMID:
21553130

Supplemental Content

Loading ...
Support Center